We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.48%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.3B
AUM Growth
+$225M
Cap. Flow
+$94.2M
Cap. Flow %
4.09%
Top 10 Hldgs %
40.24%
Holding
305
New
26
Increased
135
Reduced
93
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 10.28%
2 Healthcare 7.77%
3 Financials 4.92%
4 Industrials 4.71%
5 Communication Services 3.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOW icon
276
Dow Inc
DOW
$21.8B
$222K 0.01%
3,508
+179
+5% +$11.8K
GLW icon
277
Corning
GLW
$123B
$221K 0.01%
5,408
-86
-2% -$3.75K
DKNG icon
278
DraftKings
DKNG
$11.9B
$219K 0.01%
+4,193
New +$221K
GIS icon
279
General Mills
GIS
$19.3B
$218K 0.01%
+3,573
New +$221K
IWB icon
280
iShares Russell 1000 ETF
IWB
$48.1B
$213K 0.01%
+879
New +$207K
CODI icon
281
Compass Diversified
CODI
$756M
$212K 0.01%
+8,302
New +$210K
VB icon
282
Vanguard Morningstar Small-Cap ETF
VB
$80B
$212K 0.01%
941
-165
-15% -$36.6K
IWS icon
283
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$211K 0.01%
+1,832
New +$210K
BOTZ icon
284
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.3B
$210K 0.01%
+6,020
New +$206K
ABMD
285
DELISTED
Abiomed Inc
ABMD
$210K 0.01%
+674
New +$207K
ITOT icon
286
iShares Core S&P Total US Stock Market ETF
ITOT
$94.2B
$208K 0.01%
+2,110
New +$203K
FXB icon
287
Invesco CurrencyShares British Pound Sterling Trust
FXB
$77.5M
$207K 0.01%
1,550
JCI icon
288
Johnson Controls International
JCI
$89B
$206K 0.01%
+3,007
New +$194K
HRTX icon
289
Heron Therapeutics
HRTX
$96.3M
$185K 0.01%
+11,890
New +$189K
NAK
290
Northern Dynasty Minerals
NAK
$801M
$157K 0.01%
318,950
INVA icon
291
Innoviva
INVA
$1.56B
$144K 0.01%
+10,741
New +$134K
OCSL icon
292
Oaktree Specialty Lending
OCSL
$1.03B
$137K 0.01%
6,822
+418
+7% +$8.37K
FLG
293
Flagstar Bank National Association
FLG
$5.97B
$125K 0.01%
+3,774
New +$135K
AGRX
294
DELISTED
Agile Therapeutics
AGRX
$121K 0.01%
45
+19
+73% +$62.6K
HDSN
295
Hudson Technologies
HDSN
$246M
$114K ﹤0.01%
+33,422
New +$80.5K
ASX icon
296
ASE Group
ASX
$81B
$96K ﹤0.01%
11,938
-377
-3% -$3.03K
ADMA icon
297
ADMA Biologics
ADMA
$2B
$87K ﹤0.01%
54,186
+3,116
+6% +$5.48K
RBBN icon
298
Ribbon Communications
RBBN
$380M
$76K ﹤0.01%
10,030
RGLS
299
DELISTED
Regulus Therapeutics
RGLS
$51K ﹤0.01%
6,326
+227
+4% +$2.53K
BBIG
300
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$40K ﹤0.01%
+735
New +$31.6K

Similar funds

Grimes & Company's Q2 2021 Portfolio in Review

As of Q2 2021, Grimes & Company held 305 positions worth $2.3B, up 11% from $2.08B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grimes & Company deployed $94.2M of net new capital in Q2 2021, opening 26 new positions and adding to 135 existing holdings. Its largest new stake was Invesco Ultra Short Duration ETF: 38,101 shares worth $1.92M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Expeditors International, an estimated $10.4M trimmed.

  • Grimes & Company's largest Q2 2021 buy was Invesco Ultra Short Duration ETF: 38,101 shares worth $1.92M.
  • Grimes & Company added most to State Street Technology Select Sector SPDR ETF in Q2 2021, an estimated $14.7M increase.
  • Grimes & Company's biggest Q2 2021 reduction was Expeditors International, cutting an estimated $10.4M.
  • Grimes & Company fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $10.4M.
  • Grimes & Company's ten largest holdings make up 40% of its $2.3B portfolio in Q2 2021.
  • Grimes & Company opened 26 new positions and closed 3 in Q2 2021.
  • Grimes & Company's portfolio value rose 11% quarter-over-quarter to $2.3B.

Based on Grimes & Company's 13F filing for Q2 2021, filed 4 Aug 2021.